Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Mar 27;28(151):180119.
doi: 10.1183/16000617.0119-2018. Print 2019 Mar 31.

Cancer-associated Thrombosis: The When, How and Why

Affiliations
Free article
Review

Cancer-associated Thrombosis: The When, How and Why

Caio J Fernandes et al. Eur Respir Rev. .
Free article

Abstract

Cancer-associated thrombosis (CAT) is a condition in which relevance has been increasingly recognised both for physicians that deal with venous thromboembolism (VTE) and for oncologists. It is currently estimated that the annual incidence of VTE in patients with cancer is 0.5% compared to 0.1% in the general population. Active cancer accounts for 20% of the overall incidence of VTE. Of note, VTE is the second most prevalent cause of death in cancer, second only to the progression of the disease, and cancer is the most prevalent cause of deaths in VTE patients. Nevertheless, CAT presents several peculiarities that distinguish it from other VTE, both in pathophysiology mechanisms, risk factors and especially in treatment, which need to be considered. CAT data will be reviewed in this review.

Conflict of interest statement

Conflict of interest: C.J. Fernandes reports personal fees from Actelion, GSK and Bayer, outside the submitted work. Conflict of interest: L.T.K. Morinaga reports personal fees from Bayer, outside the submitted work. Conflict of interest: J.L. Alves Jr reports personal fees from Bayer and Actelion, outside the submitted work. Conflict of interest: M.A. Castro has nothing to disclose. Conflict of interest: D. Calderaro reports personal fees from Pfizer and Bayer, outside the submitted work. Conflict of interest: C.V.P. Jardim reports personal fees from Bayer and Actelion, and other funding from GSK (former employee), outside the submitted work. Conflict of interest: R. Souza reports personal fees from Actelion, GSK, Pfizer and Bayer, outside the submitted work.

Similar articles

See all similar articles

Cited by 3 articles

MeSH terms

LinkOut - more resources

Feedback